VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
AFGC
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
AFGCAmerican Financial Group, Inc.
$17.82$1.5B
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksAFGCQuarterly Financials

American Financial Group, Inc. (AFGC) Quarterly Financials

120+ quarters historyFree accessUpdated daily

American Financial Group, Inc. (AFGC) quarterly income statement — complete revenue, gross profit & net income history

AFGC Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue1.85B2.04B2.27B1.86B1.79B2.14B2.29B1.89B1.88B1.99B2.07B1.75B1.68B1.93B1.92B1.54B1.55B1.72B1.72B1.53B
Revenue Growth %3.69%-4.54%-0.87%-1.17%-4.94%7.55%10.63%7.83%11.76%3.06%7.7%13.65%8.65%12.28%11.94%0.52%8.25%5.92%10.63%9.12%
Medical Costs & Claims01.06B00039M0-14M-25M000-57M0000000
Medical Cost Ratio %0%51.98%0%0%0%1.82%0%-0.74%-1.33%0%0%0%-3.39%0%0%0%0%0%0%0%
Gross Profit0980M2.27B1.86B1.79B2.23B2.29B1.82B1.91B1.99B2.07B1.75B1.74B1.93B1.92B1.54B1.55B1.72B1.72B1.53B
Gross Margin %0%48.02%100%100%100%104.07%100%96.71%101.33%100%100%100%103.39%100%100%100%100%100%100%100%
Gross Profit Growth %-100%-55.96%-0.87%2.19%-6.19%11.92%10.63%4.29%9.54%3.06%7.7%13.65%12.33%12.28%11.94%0.52%2.65%5.92%10.63%-21.53%
Operating Expenses0601M00041M01.52B168M36M00164M2.81B01.33B041M0-1.24B
OpEx / Revenue %0%29.45%0%0%0%1.92%0%80.59%8.93%1.81%0%0%9.74%145.67%0%86.61%0%2.39%0%-81.19%
Depreciation & Amortization00000270M0-290M20M00020M22M027M00034M
Combined Ratio %0%81.43%0%0%0%3.74%0%79.85%7.6%1.81%0%0%6.36%145.67%0%86.61%0%2.39%0%-81.19%
Operating Income0379M2.27B1.86B1.79B-2.38B2.29B276M298M1.95B2.07B1.75B283M406M1.92B206M1.55B1.68B1.72B288M
Operating Margin %0%18.57%100%100%100%-111.37%100%14.63%15.84%98.19%100%100%16.82%21.05%100%13.39%100%97.61%100%18.81%
Operating Income Growth %-100%115.92%-0.87%575.36%500%-221.98%10.63%-84.22%5.3%380.79%7.7%749.03%-81.73%-75.79%11.94%-28.47%331.48%259.1%10.63%76.69%
EBITDA0402M287M1.86B1.79B-2.11B2.29B-14M318M1.95B2.07B1.75B303M428M1.92B233M1.55B1.68B1.72B322M
EBITDA Margin %0%19.7%12.64%100%100%-98.74%100%-0.74%16.91%98.19%100%100%18%22.19%100%15.14%100%97.61%100%21.03%
Interest Expense23M23M19M19M19M19M19M19M19M19M19M19M19M60M19M23M23M23M24M23M
Non-Operating Income0-23M-28M1.86B1.79B-1M2.29B-14M-25M1.95B2.07B1.75B-57M-185M1.92B-23M1.55B1.68B1.72B-71M
Pretax Income239M380M268M229M197M320M229M271M304M335M219M255M264M346M210M206M361M445M267M576M
Pretax Margin %12.89%18.62%11.81%12.29%11.02%14.97%10%14.37%16.16%16.85%10.58%14.58%15.69%17.94%10.93%13.39%23.31%25.9%15.55%37.62%
Income Tax48M80M53M55M43M65M48M62M62M72M42M55M52M70M45M39M71M90M48M48M
Effective Tax Rate %20.08%21.05%19.78%24.02%21.83%20.31%20.96%22.88%20.39%21.49%19.18%21.57%19.7%20.23%21.43%18.93%19.67%20.22%17.98%8.33%
Net Income191M299M215M174M154M255M181M209M242M263M177M200M212M276M165M167M290M355M219M576M
Net Margin %10.3%14.65%9.47%9.33%8.61%11.93%7.9%11.08%12.87%13.23%8.55%11.44%12.6%14.31%8.58%10.85%18.72%20.66%12.75%37.62%
Net Income Growth %24.03%17.25%18.78%-16.75%-36.36%-3.04%2.26%4.5%14.15%-4.71%7.27%19.76%-26.9%-22.25%-24.66%-71.01%-30.79%33.96%33.54%409.73%
EPS (Diluted)2.293.592.582.081.843.032.162.492.893.142.092.352.483.241.931.963.4016.2410.626.73
EPS Growth %24.46%18.48%19.44%-16.47%-36.33%-3.5%3.35%5.96%16.53%-3.09%8.29%19.9%-27.06%-80.05%-81.83%-70.88%-29.75%434.21%972.73%434.13%
EPS (Basic)2.293.582.572.081.843.042.162.492.893.142.092.352.493.241.941.963.4116.3310.676.78
Diluted Shares Outstanding83.3M83.4M83.4M83.5M83.8M84M83.9M83.9M83.8M83.8M84.7M85.2M85.4M85.3M85.4M85.3M85.2M85.6M85.2M85.6M